How Proteases Break Down Peptides

Proteases break down peptides by catalyzing cleavage of the peptide bonds that connect amino-acid residues. Different proteases recognize different sequence features and may act at the ends or within the middle of a peptide chain. The resulting fragments can differ from the original peptide in molecular mass, structure, analytical behavior, and observed activity in a research system.

Proteolytic stability is one of the main variables considered in research on the future of oral peptide delivery. Resistance to one purified enzyme does not establish stability in gastric fluid, intestinal fluid, brush-border preparations, epithelial cells, tissue extracts, or plasma-based models.

Research-use notice: InStrips products are offered for research and analytical use only. They are not intended to diagnose, treat, cure, or prevent any disease, injury, deficiency, absorption disorder, digestive condition, or medical condition.

Detection of peptide-related material after enzyme exposure does not establish that the complete starting sequence remains intact. Analytical methods must distinguish the original peptide from fragments, modified products, aggregates, and free labels.

What Is a Protease?

A protease is an enzyme that catalyzes the cleavage of proteins or peptides.

Related terms may include:

• peptidase
• proteinase
• proteolytic enzyme
• endopeptidase
• exopeptidase

The preferred term may depend on enzyme family, substrate, cleavage location, or research context.

What Is a Peptide Bond?

A peptide bond forms between amino-acid residues within a peptide chain.

A peptide containing several amino acids contains several potential bonds that may be cleaved. One cleavage can divide the original sequence into two shorter fragments.

Additional cleavage may produce:

• shorter oligopeptides
• tripeptides
• dipeptides
• individual amino acids

Fragments should not be assumed to have the same research properties as the starting peptide.

Proteolysis Uses Water

Protease-catalyzed cleavage generally involves hydrolysis. Water participates in the reaction that separates a peptide bond.

The enzyme:

• binds the peptide substrate
• positions a susceptible bond
• supports the hydrolysis reaction
• releases the resulting fragments

The enzyme can then act on additional substrate molecules under suitable conditions.

Cleavage Is Sequence Dependent

Proteases do not cleave every peptide bond equally. Many enzymes have preferences for amino-acid residues near the cleavage position.

Cleavage can be influenced by:

• the amino acid before the bond
• the amino acid after the bond
• nearby residues
• electrical charge
• steric accessibility
• peptide conformation
• chemical modification

A preferred residue may be present without being accessible to the enzyme’s active site.

Endopeptidases

Endopeptidases cleave peptide bonds within a chain rather than removing residues only from an end.

One internal cleavage may:

• divide the sequence into two fragments
• expose new terminal residues
• create additional cleavage sites
• change peptide conformation
• change chromatographic behavior

The newly formed fragments may then become substrates for other enzymes.

Exopeptidases

Exopeptidases remove amino acids or short units from peptide termini.

They may act from:

• the amino-terminal end
• the carboxyl-terminal end

Terminal modifications may reduce recognition by some exopeptidases, but they do not necessarily prevent internal cleavage.

Sequential Degradation

Proteolysis often occurs through a sequence of reactions rather than one isolated cut.

An endopeptidase may first divide a peptide into shorter fragments. Exopeptidases may then remove terminal residues from those fragments.

The resulting sample can contain:

• remaining intact peptide
• several intermediate fragments
• terminally shortened products
• individual amino acids
• chemically modified species

The composition can change continuously during an incubation experiment.

Pepsin and Acidic Conditions

Pepsin is a gastric protease commonly studied under acidic conditions.

It is generated from the precursor pepsinogen and shows preferences for selected hydrophobic or aromatic sequence regions.

Pepsin-related studies may vary in:

• pH
• enzyme concentration
• peptide concentration
• incubation time
• buffer composition
• temperature

A result obtained under one set of conditions should not be transferred automatically to another simulated gastric system.

Acid and Enzyme Effects Must Be Separated

A peptide can change under acidic conditions even without active protease.

Researchers may therefore compare:

• peptide in neutral buffer
• peptide in acidic buffer without enzyme
• peptide in acidic buffer with pepsin
• peptide with inactivated enzyme

These controls help distinguish chemical instability from enzyme-catalyzed cleavage.

Pancreatic Proteases

Pancreatic secretions contain several protease precursors that become active within the intestinal environment.

Frequently studied enzymes include:

• trypsin
• chymotrypsin
• elastase
• carboxypeptidase A
• carboxypeptidase B

These enzymes have different sequence preferences and may act together on one peptide.

Zymogens

Several digestive proteases are produced as inactive precursors called zymogens.

Examples include:

• trypsinogen
• chymotrypsinogen
• proelastase
• procarboxypeptidases

Controlled activation limits proteolytic activity before the enzymes reach their intended biological location.

Activation state should be considered when biological enzyme preparations are used in research.

Trypsin

Trypsin commonly cleaves selected peptide bonds associated with basic residues such as lysine or arginine.

Cleavage may still depend on:

• the neighboring sequence
• terminal position
• steric restriction
• peptide folding
• chemical modification
• experimental pH

Trypsin is also involved in activation of other protease precursors, contributing to a broader enzyme network.

Chymotrypsin

Chymotrypsin commonly recognizes selected aromatic or hydrophobic sequence regions.

Residues often examined in chymotrypsin-cleavage studies include:

• phenylalanine
• tyrosine
• tryptophan
• other bulky hydrophobic residues

The presence of one of these residues does not establish that cleavage will occur under every condition.

Elastase

Elastase has sequence preferences that differ from those of trypsin and chymotrypsin.

It may recognize bonds near smaller neutral amino-acid residues.

This difference illustrates why a sequence modified to reduce cleavage by one protease may remain susceptible to another enzyme.

Carboxypeptidases

Carboxypeptidases remove amino-acid residues from the carboxyl-terminal end of a peptide.

Different carboxypeptidases show different residue preferences.

Their activity can alter:

• terminal composition
• molecular mass
• electrical charge
• chromatographic retention
• recognition by analytical antibodies

Brush-Border Peptidases

The intestinal epithelial surface contains membrane-associated enzymes commonly described as brush-border peptidases.

These may include:

• aminopeptidases
• dipeptidases
• oligopeptidases
• other membrane-associated hydrolases

A peptide that remains measurable after luminal-enzyme exposure may still change when placed near brush-border membrane preparations.

Aminopeptidases

Aminopeptidases remove residues from the amino-terminal end of a peptide.

Activity may depend on:

• the first amino-acid residue
• the second residue
• terminal protection
• local charge
• peptide conformation
• enzyme subtype

Blocking the amino terminus may change susceptibility to selected enzymes but does not establish stability against all peptidases.

Intracellular Proteolysis

Peptide degradation can also occur after association with or uptake into an epithelial cell model.

Internalized material may enter:

• endosomes
• lysosomes
• recycling compartments
• cytosolic processing pathways

Lysosomal enzymes can process internalized peptides and carrier materials.

A cellular fluorescence signal may therefore represent intact peptide, fragments, carrier material, or free label.

Proteases in Tissue and Plasma Models

Researchers may also examine stability in tissue homogenates, plasma, serum, liver-derived systems, kidney-derived systems, or cell-surface enzyme preparations.

These models can contain:

• soluble proteases
• membrane-associated peptidases
• metabolic enzymes
• binding proteins
• endogenous inhibitors

Stability in a gastrointestinal enzyme model does not establish stability in these later-stage research systems.

Why One Cleavage Can Change the Result

A peptide’s research behavior may depend on its complete sequence and molecular structure.

One cleavage can change:

• target binding in an assay
• molecular conformation
• solubility
• electrical charge
• membrane interaction
• analytical detection

The properties of a fragment should be measured rather than assumed from the properties of the intact peptide.

Fragments Can Retain Assay Recognition

Some analytical methods recognize only one region of a peptide.

An antibody may continue to bind a fragment if the recognized sequence remains present. A fluorescent or radioactive label may also remain detectable after cleavage.

This can create a peptide-associated signal without confirming the full starting sequence.

Intact-Peptide Analysis

Methods used to investigate proteolysis may include:

• high-performance liquid chromatography
• ultra-performance liquid chromatography
• mass spectrometry
• tandem mass spectrometry
• capillary electrophoresis
• sequence analysis
• validated immunochemical methods

Combining separation with structural identification can help determine which molecular forms are present.

Cleavage-Site Mapping

Mass-spectrometric or sequencing methods may be used to identify the positions at which cleavage occurred.

Cleavage-site mapping can help researchers examine:

• which bonds are most susceptible
• which fragments appear first
• whether cleavage is sequential
• whether a modification changes the degradation pattern
• whether different enzymes produce different fragments

Identifying disappearance of the parent peak alone provides less information than identifying the resulting products.

Purified-Enzyme Studies

Purified enzymes allow controlled investigation of one proteolytic mechanism.

Advantages may include:

• known enzyme identity
• controlled concentration
• defined buffer conditions
• simpler fragment interpretation
• repeatable comparisons

However, purified-enzyme systems do not reproduce the full range of enzymes and biological components present in mixed gastrointestinal preparations.

Simulated Gastric and Intestinal Fluids

Simulated fluids may combine selected pH conditions, salts, surfactants, and enzymes.

Their composition can differ substantially among protocols.

Researchers should identify:

• the preparation standard
• enzyme source
• enzyme activity
• pH
• ionic composition
• incubation sequence
• sampling schedule

The label simulated intestinal fluid does not identify one universal experimental medium.

Biological Preparations

Intestinal fluid, tissue homogenates, brush-border membranes, and other biological materials may provide greater complexity than purified enzymes.

They can also introduce variability involving:

• species
• collection method
• storage
• freeze-thaw history
• endogenous inhibitors
• microbial contamination
• uncharacterized enzyme activity

Controls and activity measurements are important when comparing preparations.

Half-Life in an Enzyme Study

A degradation half-life describes the time required for the measured amount of intact peptide to decrease by half under defined conditions.

Interpretation requires information about:

• enzyme concentration
• peptide concentration
• temperature
• pH
• sampling frequency
• analytical method
• kinetic model

A half-life measured in one assay should not be presented as a universal property of the peptide.

Enzyme Activity Units

Protease concentration may be reported by mass, molarity, or activity units.

Two preparations containing the same enzyme mass may not have the same catalytic activity.

Activity can change because of:

• source
• purity
• storage
• temperature
• pH
• autolysis
• inhibitors

Reporting activity improves comparison between experiments.

Peptide Concentration

The starting peptide concentration can influence apparent degradation kinetics.

At different concentrations, researchers may observe changes in:

• enzyme-to-substrate ratio
• aggregation
• surface adsorption
• analytical sensitivity
• reaction rate
• fragment accumulation

An experimental concentration should not be selected or interpreted without considering these effects.

Sequence Modification

Researchers may alter selected sequence features to study protease recognition.

Investigated modifications may include:

• amino-acid substitution
• non-natural amino acids
• D-amino acids
• terminal modifications
• backbone changes
• cyclization
• steric shielding

A change that increases stability may also alter conformation, solubility, assay binding, aggregation, or other experimental properties.

Cyclization

Cyclization links two parts of a peptide to create a constrained structure.

This may reduce access to selected cleavage sites or change recognition by an enzyme.

The result depends on:

• ring size
• linkage position
• linkage chemistry
• sequence
• three-dimensional conformation

Cyclization does not establish resistance to all protease families.

Terminal Protection

Terminal modifications may be investigated because exopeptidases act from peptide ends.

Examples may include:

• amino-terminal acetylation
• carboxyl-terminal amidation
• attachment of protective groups
• fusion to another molecular component

These changes may reduce selected terminal cleavage pathways while leaving internal sites available.

Encapsulation

A carrier may reduce direct contact between a peptide and an enzyme preparation.

Protection depends on:

• carrier integrity
• peptide loading
• premature release
• enzyme entry into the carrier
• carrier degradation
• release after enzyme exposure

Loss of peptide from solution may reflect degradation, carrier retention, precipitation, or surface adsorption.

Protease Inhibitors

Protease inhibitors may be used experimentally to identify enzyme involvement or reduce selected cleavage reactions.

Researchers must consider:

• inhibitor specificity
• concentration
• reversibility
• stability
• interaction with the peptide
• interaction with analytical methods
• effects on cell or tissue models

Inhibition of one enzyme does not establish inhibition of the complete proteolytic environment.

Proteolysis and Mucus Transport

Peptide degradation and mucus movement can occur during the same experiment.

A peptide retained within mucus may remain exposed to enzyme activity for a longer period. A carrier moving rapidly through mucus may reach brush-border enzymes sooner.

This interaction is one reason oral peptide-delivery research involves several connected barriers.

Species Differences

Protease expression and gastrointestinal conditions vary among species.

Differences may include:

• gastric pH
• enzyme concentration
• enzyme subtype
• fluid composition
• feeding pattern
• intestinal transit
• sample-collection method

A degradation result from one species should be identified as species-specific evidence.

What a Strong Proteolysis Study Should Report

A well-described study should identify:

• the exact peptide sequence
• molecular form and purity
• enzyme identity and source
• enzyme activity
• peptide concentration
• pH and temperature
• incubation time
• controls
• analytical method
• identified fragments
• replicates and variability

General descriptions such as enzyme stable provide limited information without these details.

Reading the Scientific Literature

The open-access review Challenges and Opportunities in the Oral Delivery of Biologics describes gastric, pancreatic, luminal, and epithelial enzyme barriers considered in laboratory and translational research.

Readers should distinguish purified-enzyme findings, simulated-fluid experiments, tissue studies, animal observations, and measurements made under human experimental conditions.

Final Perspective

Proteases break down peptides through sequence-dependent cleavage of peptide bonds. Gastric proteases, pancreatic enzymes, brush-border peptidases, intracellular enzymes, and enzymes in tissue or plasma models may contribute at different stages.

Resistance to one enzyme or one experimental preparation does not establish complete proteolytic stability.

Accurate research coverage should identify the peptide sequence, molecular form, enzyme preparation, test conditions, analytical method, fragments, and limits of the model without presenting enzyme resistance as evidence of practical or clinical performance.